The worldwide CAR T-cell therapy market is experiencing significant growth, driven by rising demand for cutting-edge cancer treatment options. This exponential expansion is fueled by contributing forces such as the approval of CAR T-cell therapies for multiple treatments, advancements in production technologies, and expanding research and developme